Stay updated with breaking news from Stephen Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study demonstrates feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support London, UK - 4 January 2022
Investegate announcements from COMPASS Pathways, COMPASS Selected for Addition to NASDAQ Biotechnology Index
London, U.K., Dec. 17, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health
Investegate announcements from COMPASS Pathways, COMPASS Pathways announces changes in Executive Team
London, UK - 3 December 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced